BackTheriva Biologics Overview

Theriva Biologics Total Assets

Track Theriva Biologics's total assets ($38M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$38.25M
18.93% YoYΔ $6.09M vs prior year quarter

Peer average

Loading

Theriva Biologics Total Assets History

Loading

Theriva Biologics vs. peers: Total Assets Comparison

Loading

Theriva Biologics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Theriva Biologics (SYN) FAQ

As of the most recent data (March 2026), SYN shows a total assets of $38M. That compares with $32M in the prior-year period — up 18.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SYN's total assets is now $38M (was $32M) — a 18.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Theriva Biologics is outperforming or lagging.

Tracking SYN's total assets over time shows whether Theriva Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $38M That compares with $32M in the prior-year period — up 18.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Theriva Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $38M) with ownership activity and broader fundamentals.

Theriva Biologics's total assets is $38M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.